HOME >> MEDICINE >> NEWS
Therapeutic prospects beyond Vioxx

Philadelphia, PA Researchers at the University of Pennsylvania School of Medicine have clarified the mechanism by which drugs like Celebrex and Vioxx cause heart problems, in multiple animal models. The findings offer the prospect of a new generation of anti-inflammatory drugs that bypass this issue, as reported in the April 13 advanced online edition and May print issue of The Journal of Clinical Investigation.

"Although these results are in mice, not people, they raise an exciting possibility which can be tested in humans," says senior author Garret FitzGerald, MD, Director of Penn's Institute for Translational Medicine and Therapeutics,

Ever since the association of selective inhibitors of COX-2 Vioxx, Bextra, and Celebrex with an increased incidence of heart attack and stroke, there has been intense interest in understanding the mechanism involved. Clarification of this issue offers the prospect of conserving the clinical benefit of these drugs for patients with arthritis, while managing the risk.

Almost 10 years ago, FitzGerald noticed that both Celebrex and Vioxx depressed in healthy individuals a protective fat called prostacyclin, while leaving unaltered a harmful one called thromboxane. This led him to predict that drugs in this class might confer a cardiovascular risk before either reached the US market.

In the present studies, the investigators used multiple genetically manipulated mice including mice that mimicked the impact of either COX-2 inhibitors or low-dose aspirin and compared them with treating healthy mice with COX-2 inhibitors, such as Celebrex. They found that genetic disruption of COX-2; inhibition of the enzyme by different inhibitors; and disruption of prostacyclin's effects by removing its receptor all had the same effect a predisposition to clotting and an elevation of blood pressure. "This provides compelling evidence in support of the original hypothesis," says co-author Colin Funk, PhD, who has co
'"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-662-2560
University of Pennsylvania School of Medicine
13-Apr-2006


Page: 1 2 3

Related medicine news :

1. Therapeutic unshackles p53 and causes tumor regression
2. Tibotec Therapeutics announces start of largest US study on HIV treatment in women
3. Therapeutic role found for carbon monoxide
4. Therapeutic communities: A three country comparison
5. Therapeutic vaccine for ovarian cancer in clinical trials
6. Brightening prospects of using fluorescent nanotubes in medical applications
7. A broader look at cardiac CTA images often finds diseases/disorders beyond the heart
8. Pharmacists go beyond the counter to help hospitalized patients
9. Technology to improve care at the bedside and beyond
10. Hazardous alcohol use by young adults goes far beyond college campuses
11. Lessons from Vioxx case -- New approach needed to restore faith in pharmaceutical industry

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... , ... August 31, 2020 , ... A Cure for Covid-19 “PTS” with Mediation & ... the planet are in a state of panic, experiencing deep anxiety, immense stress, and right ... a solution is timely when most people on the planet are experiencing a great degree ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... directly with persons with autism and other developmental disabilities, as well as supporting ... parent education, adolescents with autism, school consultation, and staff development. She joined the ...
(Date:8/29/2020)... , ... August 29, 2020 , ... When professor and ... with greater ease than most people would. Rather than become melancholic, however, he put ... advice on achieving one’s dreams. Randy Pausch took a negative situation and turned it ...
(Date:8/28/2020)... Ariz. (PRWEB) , ... August 28, 2020 , ... ... respiratory assist system designed to help treat patients with respiratory conditions, including COVID-19, ... mixture of helium and oxygen, but it captures exhaled gas and scrubs it ...
(Date:8/28/2020)... ... August 28, 2020 , ... With in-person gluten-free events being ... helping the specialty-diet community connect with great, gluten-free brands. At the Online ... chat with brands & watch over 50 educational classes... all online from the ...
Breaking Medicine News(10 mins):
(Date:8/28/2020)... ... August 28, 2020 , ... Dr. Raheleh Sarbaziha has been ... and approach. Armed with her qualifications from Ross University School of Medicine and ... the human body with the nation and world. With a fellowship in Integrative ...
(Date:8/27/2020)... ... August 27, 2020 , ... The flu season is right round the corner and ... equipped with all the necessary measures before it begins to harbor its effects on us. ... it is leaving a huge impact on our lives. Hence it has become even more ...
(Date:8/27/2020)... MYERS, Fla. (PRWEB) , ... August 27, 2020 , ... ... Board of Directors. Dr. Friedman is an adult and pediatric neuro-oncologist who serves on ... University and as an educator at Duke University Medical School. , Internationally recognized, Dr. ...
Breaking Medicine Technology:
Cached News: